Why the IMNN-001 and PARP inhibitor pairing could matter more than the standalone data in ovarian cancer
FDA engagement signals cautious progress for AEON Biopharma Inc. in complex biologics space (NYSE American: AEON)
Read More 2 minute read General business news Munich Re’s ERGO to buy 25% stake in China-based Taishan Insurance Germany-based ERGO Group, a subsidiary of Munich Re, has agreed to acquire a 24.9% stake in Taishan Property… byPallavi MadhirajuJune 8, 2020
